On Nov 14, major Wall Street analysts update their ratings for $Surgery Partners (SGRY.US)$, with price targets ranging from $31 to $50.
Barclays analyst Andrew Mok CFA maintains with a hold rating, and maintains the target price at $31.
Jefferies analyst Brian Tanquilut maintains with a buy rating, and adjusts the target price from $47 to $40.
TD Cowen analyst Ryan Langston maintains with a buy rating, and adjusts the target price from $36 to $32.
Benchmark Co. analyst Bill Sutherland maintains with a buy rating, and maintains the target price at $50.
Furthermore, according to the comprehensive report, the opinions of $Surgery Partners (SGRY.US)$'s main analysts recently are as follows:
The operating environment for Surgery Partners continues to be favorable, however, specific challenges are believed to modestly prolong the trajectory towards positive free cash flow.
The company's recent financial results were consistent with expectations, and its forecast for revenue and adjusted EBITDA was reaffirmed. The projection for free cash flow was moderated in light of increased expenditure on transactions and other factors. The firm highlighted that the organization's organic revenue growth is driven by case volume, and despite a mix shift influencing the rate, performance remains robust for the year so far.
Here are the latest investment ratings and price targets for $Surgery Partners (SGRY.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
